4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001493152-24-011215
Options or other derivatives
- Chief Executive Officer acquired 370,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Alder Matthias · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-21 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +370,000 | 370,000 | D |
Loading xslF345X05/ownership.xml…